KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Change in Account Payables (2016 - 2025)

Elevance Health (ELV) has disclosed Change in Account Payables for 17 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 4032.14% to $1.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $228.0 million, a 112.39% increase, with the full-year FY2025 number at $228.0 million, up 112.39% from a year prior.
  • Change in Account Payables was $1.1 billion for Q4 2025 at Elevance Health, up from -$1.3 billion in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.5 billion in Q1 2021 to a low of -$1.4 billion in Q2 2024.
  • A 5-year average of $173.4 million and a median of $236.0 million in 2021 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: crashed 725.0% in 2023, then skyrocketed 4032.14% in 2025.
  • Elevance Health's Change in Account Payables stood at $195.0 million in 2021, then soared by 322.05% to $823.0 million in 2022, then plummeted by 122.6% to -$186.0 million in 2023, then surged by 84.95% to -$28.0 million in 2024, then surged by 4032.14% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Change in Account Payables are $1.1 billion (Q4 2025), -$1.3 billion (Q3 2025), and -$213.0 million (Q2 2025).